What does this research mean for the field?

Hyperuricemia is a significant cardiovascular and renal risk factor that contributes to residual CVD risk, warranting targeted management and dietary improvements, though routine treatment of asymptomatic cases requires further validation from randomized trials. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the pathophysiological mechanisms linking hyperuricemia to cardiovascular disease and evaluate the clinical necessity of targeted urate-lowering interventions.

September 8, 2026Cardiology in Review

Uric Acid and Cardiovascular Disease

View Full Paper

Ask AI

Bookmark

Authors

AMAntonis A. Manolis TMTheodora A. Manolis AVApostolos Vouliotis

Discussion

Member takes

Overview

Narrative review identifies hyperuricemia as an independent cardiovascular risk factor, highlighting the need for targeted urate-lowering strategies in high-risk patients.

Key Points

To review the pathophysiological mechanisms linking hyperuricemia to cardiovascular disease and evaluate the clinical necessity of targeted urate-lowering interventions.
Examined mechanistic pathways driving excessive uric acid production and impaired renal excretion in metabolic and vascular diseases.
Evaluated clinical evidence regarding serum urate testing, dietary quality, and cardiovascular risk stratification.
Hyperuricemia confers residual cardiovascular risk and worsens prognosis, even in patients with cardiovascular disease whose low-density lipoprotein cholesterol is controlled by statins.
Serum urate measurements improve clinical risk stratification in selected high-risk cohorts, although routine intervention for asymptomatic hyperuricemia remains unsupported.
Poor dietary patterns and unbalanced macronutrient intake are prevalent among patients with hyperuricemia, underscoring the need for nutritional optimization alongside prospective randomized trial data.

Cite This Study

Manolis et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd7c658e84d0ff5b46c3e https://doi.org/10.1097/crd.0000000000001460

View Full Paper

Ask AI

Bookmark

September 8, 2026Cardiology in Review

Uric Acid and Cardiovascular Disease

View Full Paper

Ask AI

Bookmark

Authors

AMAntonis A. Manolis TMTheodora A. Manolis AVApostolos Vouliotis

Discussion

Member takes

Overview

Narrative review identifies hyperuricemia as an independent cardiovascular risk factor, highlighting the need for targeted urate-lowering strategies in high-risk patients.

Key Points

To review the pathophysiological mechanisms linking hyperuricemia to cardiovascular disease and evaluate the clinical necessity of targeted urate-lowering interventions.
Examined mechanistic pathways driving excessive uric acid production and impaired renal excretion in metabolic and vascular diseases.
Evaluated clinical evidence regarding serum urate testing, dietary quality, and cardiovascular risk stratification.
Hyperuricemia confers residual cardiovascular risk and worsens prognosis, even in patients with cardiovascular disease whose low-density lipoprotein cholesterol is controlled by statins.
Serum urate measurements improve clinical risk stratification in selected high-risk cohorts, although routine intervention for asymptomatic hyperuricemia remains unsupported.
Poor dietary patterns and unbalanced macronutrient intake are prevalent among patients with hyperuricemia, underscoring the need for nutritional optimization alongside prospective randomized trial data.

Cite This Study

Manolis et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd7c658e84d0ff5b46c3e https://doi.org/10.1097/crd.0000000000001460

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark